This Month
ASX wipes $32b; Tariffs to hit pharma; $1.3trn trade unwinds
Read everything that’s happened in the news so far today.
John Wylie’s Tanarra picks up stake in Dan Murphy owner Endeavour
The asset manager run by the prominent former banker has a long history of agitating for change. It joins the register at a time of board uncertainty.
March
Why John and Myriam Wylie are funding a new policy think tank
The investment banker and his wife have enlisted high-profile directors from all over the country to advise the new Policy Institute of Australia.
Mullen is on the money on genuine board diversity
The right way forward is a proactive approach to genuine diversity that would rightly reject performative box-ticking.
Brookfield drops out of boosted $3.4b Insignia bidding war
But other prospective bidders, Bain Capital and CC Capital, have lobbed higher $5-per-share offers for the near 180-year-old institution once known as IOOF.
Unpicking gripes aplenty around the boardroom table
Founders are “misfits and nonconformists who don’t fit into nice boxes ... but they do create nice companies,” says veteran investor John Wylie.
February
John Wylie calls for annual director elections in ASX overhaul
The veteran fund manager is urging the ASX governance council to return to the drawing board and has proposed an alternative “commonsense” version of rules.
Corporate revolt set to kill off ASX diversity plan
At least four key business groups will oppose proposals to update the governance rules, killing the prospects of getting the broad consensus needed to proceed.
Anything less than $5 for Insignia is opportunistic, says shareholder
Indian Pacific’s Preston Hamersley told Street Talk he finds himself in a bittersweet position as bids for the ASX-listed wealth manager rain down.
January
Tanarra Capital readies $400m exit at SaaS business Health Metrics
Sources said as a growing SaaS player, Health Metrics could be valued at between 6-times to 8-times revenue. That’s as much as $400 million.
Banker John Wylie wants Telstra to sell off NBN income stream
The fund manager and Telstra shareholder is urging the telco giant to package up cash payments it receives from NBN Co and sell them to boost its stock price.
Tennis Australia raises almost $50m for sports and entertainment fund
Backers of its AO Ventures vehicle include major investors such as John Wylie and Caledonia’s Mark Nelson, along with Tesla chairwoman Robyn Denholm.
John Wylie’s Tanarra Capital takes Nine stake after share price slide
The former investment banker is known for pushing companies his firm holds stakes in, from Lendlease to Tabcorp, to make major changes and spin off assets.
November 2024
Macquarie, Wylie lead charge into Japan as deal activity surges
In a country once closed to foreign investors, companies are looking for new sources of capital and selling assets. But it isn’t easy getting through the door.
October 2024
Wylie to vote against Lendlease pay report in push for board changes
John Wylie’s Tanarra Capital will consider calling an extraordinary general meeting to force board changes at the property giant.
John Wylie is betting venture capital’s business model must change
The veteran investor wants to marry Australia’s world-class intellectual property with our world-class retirement system.
UniSuper withdraws Tanarra Credit Partners’ mandate; dealmaker resigns
The industry fund has yanked a multimillion-dollar private debt mandate as it seeks to consolidate its private credit strategy towards the bigger end of town.
September 2024
Tanarra Capital says at $835m the price is right for Healius
Shares in the pathology company jumped 7.5 per cent after it achieved a robust price for Lumus, which does MRI, X-rays and CT scans.
John Wylie’s Tanarra urges Healius to halt $700m imaging business sale
The country’s second-largest pathology group has been considering selling its Lumus division. But the outspoken investor says it’s going too well to offload.
August 2024
John Wylie’s Tanarra takes softly-softly approach at NZ wool play
The business makes around $20 million in earnings before interest, tax, depreciation and amortisation on revenue of circa $60 million.